Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees, the drugmaker says.

Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...

AstraZeneca appointed Iskra Reic, PhD as its next EVP of international on Wednesday amid the ongoing controversy surrounding its former international chief, Leon Wang, who is under investigation in ...

Leon Wang was described as cooperating "with an ongoing investigation", ... According to his LinkedIn page, Wang joined AstraZeneca in 2013 and became the company's country president in 2014.

Last week, the company disclosed that Leon Wang, its executive vice president for international operations and the president of its subsidiary in China, was under investigation by authorities.The ...

AstraZeneca (NASDAQ: AZN) and Pfizer (NYSE: PFE) -- along with one biotech stock, Exelixis (NASDAQ: EXEL). (AstraZeneca): ...

The disclosure comes after AstraZeneca last week acknowledged that Leon Wang, an executive vice president who also oversees international operations for the drugmaker, was being investigated along ...

AstraZeneca on Wednesday named Iskra Reic as its new international executive vice president (EVP), taking over from Leon Wang, who was detained by Chinese authorities in October.

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but the company has very little information about the case, its CEO said on ...

Leon Wang, the president of AstraZeneca’s China division, has been placed under investigation by local police. Pascal Soriot, the company’s chief executive, last month said the company was ...

Leon Wang, president of AstraZeneca’s China division, is under investigation by local police - AstraZeneca. AstraZeneca said it would fully cooperate with the latest investigation if requested.

Citing sources, the report adds that Leon Wang, President of AstraZeneca China, is cooperating with authorities in a rapidly expanding investigation that now involves multiple government bodies, ...